We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Phytopharm | LSE:PYM | London | Ordinary Share | GB00BCLY7L40 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 58.00 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:4969T Phytopharm PLC 19 December 2003 BLOCKLISTING SIX MONTHLY REVIEW 1. NAME OF COMPANY: PHYTOPHARM PLC 2. NAME OF SCHEME: THE PHYTOPHARM 1996 UNAPPROVED DISCRETIONARY SHARE OPTION SCHEME 3. PERIOD OF RETURN: FROM: 11 JUNE 2003 TO: 10 DECEMBER 2003 4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD: 260,000 ORDINARY SHARES OF 1 PENCE 5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: 127,024 ORDINARY SHARES OF 1 PENCE 6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 132,976 ORDINARY SHARES OF 1 PENCE 7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION: 260,000 ORDINARY SHARES OF 1 PENCE ON 10TH DECEMBER 2001 PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS. TOTAL SHARES IN ISSUE 38,805,218 ORDINARY SHARES OF 1 PENCE AT 10 DECEMBER 2003 CONTACT FOR QUERIES NAME: DR G W CHONG TELEPHONE: 01480 437697 This information is provided by RNS The company news service from the London Stock Exchange END BLRUKASRORRUAAA
1 Year Phytopharm Chart |
1 Month Phytopharm Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions